Abstract Case reports of severe idiopathic portal hypertension (IPH) requiring liver transplantation are very rare. We report the case of a 65-year-old woman who was diagnosed as having IPH. At the age of 60 years, her initial symptom was hematemesis, due to ruptured esophageal varices. Computed tomography of the abdomen showed splenomegaly and a small amount of ascites, without liver cirrhosis. She was diagnosed as having IPH and followedup as an outpatient. Five years later, she developed symptoms of a common cold and rapidly progressive abdominal distension. She was found to have severe liver atrophy, liver dysfunction, and massive ascites. Living donor liver transplantation was then performed, and her postoperative course was uneventful. Histopathological findings of the explanted liver showed collapse and stenosis of the peripheral portal vein. The areas of liver parenchyma were narrow, while the portal tracts and central veins were approximate one another, leading to a diagnosis of IPH. There was no liver cirrhosis. The natural history of refractory IPH could be observed in this case. Patients with end-stage liver failure due to severe IPH can be treated by liver transplantation.
Introduction
Idiopathic portal hypertension (IPH) is a relatively rare disease, and it has been reported mostly in patients from Japan [1] ). Most patients with IPH have a good prognosis with treatment for their esophagogastric varices, but some develop end-stage liver failure despite various medical treatments [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . Such end-stage liver failure is an indication for liver transplantation, but details of such cases have not been fully reported in the literature. We treated a patient with severe IPH who required living donor liver transplantation (LDLT); this case allows one to observe the natural history of severe refractory IPH.
Case Report
A 65-year-old woman who had been followed-up for IPH at our hospital developed abdominal distension. At the age of 60 years, the patient presented with sudden hematemesis and was taken to a nearby hospital. On emergent upper gastrointestinal endoscopy, the ruptured esophageal varices were successfully ligated. Subsequently, the patient was transferred to our hospital.
On her admission, her vital signs (heart rate, blood pressure, respiratory rate, and body temperature) were stable. On physical examination, her abdomen was soft, flat, and not tender. Her spleen was palpable, but her liver was not. She did not have encephalopathy. The patient denied any history of blood transplantation, alcohol abuse, or medications. Laboratory data showed pancytopenia (hemoglobin 9.4 g/dl; platelet count 4.5 9 10 4 /ll, and white blood cell count 1,300 /ll). Results of liver and renal function tests and electrolytes were normal. Her prothrombin time was slightly prolonged (73%). Hepatitis B surface antigen, hepatitis C virus antibody, and anti-mitochondria antibody were all negative.
Computed tomography of the abdomen showed splenomegaly, incomplete extrahepatic portal vein thrombus, and a slight volume of free peritoneal fluid, but no hepatomegaly, liver cirrhosis, or liver tumors (Fig. 1a) . The gastrointestinal tract, gallbladder, pancreas, kidneys, and genital organs were unremarkable. There was no obstruction of the extrahepatic portal vein or the inferior vena cava. Upper gastrointestinal endoscopy showed persistent esophageal varices.
The patient had portal hypertension that consisted of esophageal varices, splenomegaly, and pancytopenia. Laboratory data showed that liver function was completely normal, and liver cirrhosis was not found on imaging, though liver biopsy was not performed. Obstruction of the extrahepatic portal vein and the inferior vena cava, hematological malignancies, and other known diseases were ruled out. IPH was diagnosed, and the patient was followed routinely at our hospital as an outpatient, during which time she was prescribed propranolol and warfarin. Her condition remained quite stable and uneventful for 5 years.
At the age of 65 years, she developed symptoms of the common cold and rapidly progressive abdominal distension. At that time, laboratory data showed anemia (hemoglobin 7.5 g/dl), but normal platelet and white cell counts. Serum aspartate aminotransferase, alanine aminotransferase, and total bilirubin levels were normal. Her serum albumin level had decreased to 2.6 g/dl. Her prothrombin time was 44%, which was drastically prolonged, despite vitamin K administration. She also had acute renal failure (blood urea nitrogen 61 mg/dl; serum creatinine 3.8 mg/dl). Computed tomography showed massive ascites, and volumetry showed that her liver was atrophic, with only 44% of the volume of that 5 years earlier (Fig. 1b) . Extrahepatic portal vein thrombus, which had been found 5 years earlier, had disappeared. The Child-Pugh score was 11 points, and the model of end-stage liver disease (MELD) score was 23 points. She was diagnosed as having non-reversible, end-stage liver failure, and she underwent liver transplantation.
At laparotomy, she had 15 l of free intraperitoneal fluid. The liver was extremely atrophic; the resected whole liver weight was only 620 g. An extended left lobe liver graft, weighting 400 g, was transplanted from her husband. The graft weight standard liver volume rate was 36.8%. A total splenectomy was also performed. The patient's postoperative course was uneventful, and she was discharged 50 days after surgery. Five months after transplantation, the patient developed enterocolitis caused by cytomegalovirus infection; she died from peritonitis following perforation of the small intestine.
The explanted liver at the time of the LDLT was atrophic, with a wavy surface. On histopathology, there was collapse and stenosis of the peripheral portal vein (Fig. 1c) . The areas of liver parenchyma had become narrow, so that the portal tracts and central veins were approximate to one another. The entire specimen showed narrowing of the liver parenchyma, which was especially severe near the capsule. Inflammatory cells and dilated abnormal vessels were seen around the portal tracts. There were no pseudolobules or bridging folds. The histopathology findings were compatible with IPH. There was no liver cirrhosis or evidence of malignancy.
Discussion
Portal hypertension is usually caused by liver cirrhosis, but some cases of portal hypertension occur without cirrhosis. Sinusoidal portal hypertension of unknown etiology is regarded as IPH clinically. When diagnosing IPH, one must rule out liver cirrhosis, obstruction of the extrahepatic portal vein and the inferior vena cava, blood diseases, parasitic diseases, granulomatous hepatic disease, congenital liver fibrosis, chronic viral hepatitis, primary biliary cirrhosis, and other known diseases [12] . IPH has been found in 2.1-2.6% of livers at autopsy [13, 14] . IPH is associated with a spectrum of histological lesions, including incomplete septal cirrhosis, nodular regenerative hyperplasia, and partial nodular transformation [14] [15] [16] . The lesions show some degree of uneven fibrosis but may coexist in the same liver. In our patient, typical findings of incomplete septal cirrhosis, nodular regenerative hyperplasia, or partial nodular transformation were not seen. The pathogenesis of IPH is unclear, but IPH can occur in association with a variety of developmental, vascular, collagen vascular, or biliary tract diseases [6, 8, 11] . Renal failure with or without transplantation and the toxic effects of some drugs may be related to IPH [5, 8, 10, 11] . Common symptoms of IPH include splenomegaly, pancytopenia, gastrointestinal bleeding, ascites, and encephalopathy. Patients with IPH can be treated by the usual approaches: (a) long-term medical therapy, along with balloon tamponade and vasoactive drugs for bleeding esophageal varices; (b) endoscopic variceal ligation and sclerotherapy for both long-term and short-term treatment, and (c) portosystemic shunt procedures (portocaval, mesocaval, or radiological) or evascularization surgery [8] . In general, IPH does not progress to liver cirrhosis or hepatocellular carcinoma. The prognosis for patients with IPH is mostly good, if the gastrointestinal bleeding can be controlled. However, some cases of IPH progress to end-stage liver failure.
In our case, the patient developed symptoms of the common cold and rapidly progressive abdominal distension. Collagen diseases and autoimmune disorders are known to be associated with IPH [10, 11] . The immune system plays a role in IPH, so infection may be one of the progressive factors for IPH. Though a decrease in hepatic blood flow is considered to relate to IPH progression, it is unclear whether a decrease in hepatic blood flow affected acute deterioration in this case [11] . Portal vein thrombus is one of the causes for decreased hepatic blood flow, but it was not found during the operation or in the explanted liver specimen.
Some patients with IPH which is resistant to all other therapies may be successfully treated by orthotopic liver transplantation (OLT). Several case reports dealing with OLT for severe IPH are summarized in Table 1 [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . If these previous reports and ours are taken into account, there were 40 patients (30 men, 10 women) with a mean age at transplantation of 45.5 years (range 20-65 years). Gastrointestinal varices, splenomegaly, and ascites were commonly seen in patients with severe IPH who required OLT, but these symptoms are common in IPH (Table 2) . No specific symptoms characterize severe IPH. Eleven patients were treated for varices, seven by sclerotherapy and four by endoscopic variceal ligation, and nine patients underwent pretransplantation portosystemic shunting procedures (six transjugular intrahepatic portosystemic shunts and three mesocaval shunts) ( Table 3 ). The time between the clinical manifestations of portal hypertension and liver transplantation ranged from 2 months to 14 years, with a mean of 4.6 years. Patients underwent OLT because of rapidly progressing, life-threatening, complications of portal hypertension and liver disease and the inefficacy of surgical or radiological portosystemic shunting. Combined liver and kidney transplantation is performed in patients with associated severe renal failure [5, 8, 10] . Most patients with severe IPH described in the literature were well following OLT. Four patients died in the early posttransplantation period, due to herpes zoster encephalitis, suicide, sudden rupture of an unsuspected splenic aneurysm, and pneumonia [2, 8, 11] . Three patients showed evidence suggestive of recurrence of IPH in the graft liver. One patient developed symptoms 1 year after OLT [11] ; two patients were asymptomatic, though their liver biopsy findings after OLT suggested recurrence [8, 11] .
Making a pretransplantation diagnosis of IPH is difficult; 23 of the 40 patients with IPH were believed clinically to have cirrhosis, based on the clinical presentation, the 
